736 results on '"Zaorsky, Nicholas G."'
Search Results
102. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma
103. MicroRNA-223 Enhances Radiation Sensitivity of U87MG Cells In Vitro and In Vivo by Targeting Ataxia Telangiectasia Mutated
104. Effects of interruptions of external beam radiation therapy on outcomes in patients with prostate cancer
105. The Role of Genomic Techniques in Predicting Response to Radiation Therapy
106. Exposure to radon and heavy particulate pollution and incidence of brain tumors
107. Adjuvant radiotherapy may not significantly change outcomes in high-risk cutaneous squamous cell carcinomas with clear surgical margins: A systematic review and meta-analysis
108. A Patient-Level Data Meta-analysis of the Abscopal Effect
109. Long-Term Risk of Death From Heart Disease Among Breast Cancer Patients
110. Radiotherapy and chemotherapy are associated with improved outcomes over surgery and chemotherapy in the management of limited-stage small cell esophageal carcinoma
111. Reply to Editorial Comments on “Major Complications and Adverse Events Related to Use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy”
112. Starting the conversation: A seminar on genitourinary cancer care for sexual and gender minorities.
113. Exposure to radon and heavy particulate pollution and incidence of brain tumors.
114. Aspirin and Statin Nonuse Associated With Early Biochemical Failure After Prostate Radiation Therapy
115. Assessing the Value of an Optional Radiation Oncology Clinical Rotation During the Core Clerkships in Medical School
116. Impact of MRI-Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-Analysis
117. Exercise: A Treatment That Should Be Prescribed With Radiation Therapy
118. Levels of Evidence for Radiation Therapy Recommendations in the National Comprehensive Cancer Network (NCCN) Clinical Guidelines
119. Brachytherapy for Prostate Cancer: An Overview
120. List of Contributors
121. Current treatment and future directions in the management of anal cancer
122. Elective Nodal Radiotherapy for Prostate Cancer: For None, Some, or all?
123. Medical Service Use and Charges for Cancer Care in 2018 for Privately Insured Patients Younger Than 65 Years in the US
124. Long-Term Risk of Death From Heart Disease Among Breast Cancer Patients
125. The Epidemiology of Lung Metastases
126. Pan‐cancer analysis of prognostic metastatic phenotypes
127. Impact of radiation therapy facility volume on survival in patients with cancer
128. Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials
129. Potential Winners and Losers: Understanding How the Oncology Care Model May Differentially Affect Hospitals
130. Authors’ Reply: To the Letter to the Editor by Kessel et al
131. Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer
132. Image-Guided Focused Ultrasound for the Treatment of Bone Metastases: Current Status and Future Direction
133. Sex Differences in Academic Productivity Across Academic Ranks and Specialties in Academic Medicine
134. Prehabilitation exercise therapy for cancer: A systematic review and meta‐analysis
135. Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid Cancers (ROCKIT): A Meta-Analysis of 13 Studies
136. Survival after palliative radiation therapy for cancer: The METSSS model
137. Impact of Facility Surgical Volume on Survival in Patients With Cancer
138. Chondrosarcoma of the hyoid bone: Case report and review of current management options
139. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
140. Reply to Francesco Montorsi, Alessandro Larcher, and Umberto Capitanio’s Letter to the Editor re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30157-9. https://doi.org/10.1016/j.euf.2019.06.002. [Epub ahead of print]
141. A systematic review and meta-analysis of the prognostic value of radiomics based models in non-small cell lung cancer treated with curative radiotherapy
142. Unknown Causes of Death in Cancer Patients
143. Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control
144. Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer
145. Oncology training programs: are we doing comparative effectiveness research justice?
146. Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer
147. Evolution of advanced technologies in prostate cancer radiotherapy
148. Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic
149. Trends in Cancer Incidence in US Adolescents and Young Adults, 1973-2015
150. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.